121 related articles for article (PubMed ID: 8154891)
1. [The effect of suramin on human lung cancer cell line in vitro].
Fujiuchi S; Tsuji T; Ohsaki Y; Kikuchi K
Gan To Kagaku Ryoho; 1994 Apr; 21(5):647-52. PubMed ID: 8154891
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer.
Kalli KR; Bradley SV; Fuchshuber S; Conover CA
Gynecol Oncol; 2004 Sep; 94(3):705-12. PubMed ID: 15350362
[TBL] [Abstract][Full Text] [Related]
3. [The enhancement of the chemotherapeutic effects on human prostate cancer cell--the combination with the growth factor interaction inhibitor (suramin)].
Suzuki Y; Miwa Y; Akino H; Fujita T; Saikawa S; Kanimoto Y; Okada K
Hinyokika Kiyo; 1993 Dec; 39(12):1215-20. PubMed ID: 8285172
[TBL] [Abstract][Full Text] [Related]
4. Stimulatory effect of suramin on the proliferation of human glioma cells.
Kuratsu J; Kurino M; Fukunaga K; Miyamoto E; Ushio Y
Anticancer Res; 1995; 15(4):1263-8. PubMed ID: 7654006
[TBL] [Abstract][Full Text] [Related]
5. Suramin inhibits the growth of non-small-cell lung cancer cells that express the epidermal growth factor receptor.
Fujiuchi S; Ohsaki Y; Kikuchi K
Oncology; 1997; 54(2):134-40. PubMed ID: 9075785
[TBL] [Abstract][Full Text] [Related]
6. [Effects of suramin on cell proliferation of various types of human malignant cells].
Bai LY; Miyazaki M; Namba M
Gan To Kagaku Ryoho; 1991 Mar; 18(3):387-91. PubMed ID: 1848419
[TBL] [Abstract][Full Text] [Related]
7. [Influence of suramin on the proliferation of prostatic carcinoma cells PC-3M].
Xing YF; Lu GC; Xiao YJ; Zeng FQ; Zhang QJ; Feng W
Zhonghua Nan Ke Xue; 2003 Aug; 9(5):338-40. PubMed ID: 14513638
[TBL] [Abstract][Full Text] [Related]
8. Suramin disrupts insulin-like growth factor-II (IGF-II) mediated autocrine growth in human SH-SY5Y neuroblastoma cells.
Sullivan KA; Kim B; Buzdon M; Feldman EL
Brain Res; 1997 Jan; 744(2):199-206. PubMed ID: 9027379
[TBL] [Abstract][Full Text] [Related]
9. Radiation-induced enhanced proliferation of human squamous cancer cells in vitro: a release from inhibition by epidermal growth factor.
Kavanagh BD; Lin PS; Chen P; Schmidt-Ullrich RK
Clin Cancer Res; 1995 Dec; 1(12):1557-62. PubMed ID: 9815956
[TBL] [Abstract][Full Text] [Related]
10. Effects of suramin on expression of proliferation associated nuclear antigens in DU-145 prostate carcinoma cells.
Qiao L; Pizzolo JG; Melamed MR
Biochem Biophys Res Commun; 1994 Jun; 201(2):581-8. PubMed ID: 7911660
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc.
Nass SJ; Dickson RB
Clin Cancer Res; 1998 Jul; 4(7):1813-22. PubMed ID: 9676860
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop.
Schrell UM; Gauer S; Kiesewetter F; Bickel A; Hren J; Adams EF; Fahlbusch R
J Neurosurg; 1995 Apr; 82(4):600-7. PubMed ID: 7897522
[TBL] [Abstract][Full Text] [Related]
13. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
Siu SW; Lau KW; Tam PC; Shiu SY
Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702
[TBL] [Abstract][Full Text] [Related]
14. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY
Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone attenuation of epidermal growth factor-induced mitogenesis.
Wiepz GJ; Houtman JC; Cha D; Bertics PJ
J Cell Physiol; 1997 Oct; 173(1):44-53. PubMed ID: 9326448
[TBL] [Abstract][Full Text] [Related]
16. Suramin blocks binding of interleukin-4 to its receptors on human tumor cells and interleukin-4-induced mitogenic response.
Leland P; Obiri N; Aggarwal BB; Puri RK
Oncol Res; 1995; 7(5):227-35. PubMed ID: 8534928
[TBL] [Abstract][Full Text] [Related]
17. Suramin inhibits the phosphorylation and catalytic activity of DNA topoisomerase II in human lung cancer cells.
Funayama Y; Nishio K; Takeda Y; Kubota N; Ohira T; Ohmori T; Ohta S; Ogasawara H; Hasegawa S; Saijo N
Anticancer Res; 1993; 13(6A):1981-8. PubMed ID: 8297104
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer cells generated during intermittent androgen ablation acquire a growth advantage and exhibit changes in epidermal growth factor receptor expression.
Hobisch A; Fiechtl M; Sandahl-Sorensen B; Godoy-Tundidor S; Artner-Dworzak E; Ramoner R; Bartsch G; Culig Z
Prostate; 2004 Jun; 59(4):401-8. PubMed ID: 15065088
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory effect of suramin on telomerase activity and spheroid growth of C6 glioma cells.
Erguven M; Akev N; Ozdemir A; Karabulut E; Bilir A
Med Sci Monit; 2008 Aug; 14(8):BR165-73. PubMed ID: 18667993
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines.
Nishio K; Ishida T; Arioka H; Kurokawa H; Fukuoka K; Nomoto T; Fukumoto H; Yokote H; Saijo N
Anticancer Res; 1996; 16(6B):3387-95. PubMed ID: 9042196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]